Unknown

Dataset Information

0

Early tumour size changes from neoadjuvant chemotherapy as a predictor of pathologic response in breast cancer

ABSTRACT: Raw data of the ultrasound size measurements of the primary breast tumour at multiple times during neoadjuvant chemotherapy for breast cancer.

ORGANISM(S): Homo sapiens (human)

SUBMITTER: Gregory Czarnota 

PROVIDER: S-BSST2798 | biostudies-other |

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy.
| S-EPMC3776985 | biostudies-literature
Unknown Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy.
| S-EPMC4819747 | biostudies-literature
Unknown Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival.
| S-EPMC10904968 | biostudies-literature
Unknown Predictors of Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
| S-EPMC12371429 | biostudies-literature
Unknown Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
| S-EPMC10587331 | biostudies-literature
Unknown Pathologic tumor response to neoadjuvant chemotherapy in gastroesophageal cancer: what does it mean?
| S-EPMC5244799 | biostudies-literature
Unknown Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy.
| S-EPMC7475504 | biostudies-literature
Transcriptomics Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy
2017-11-17 | GSE106977 | GEO
Transcriptomics Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
2011-05-11 | E-GEOD-25066 | biostudies-arrayexpress
Unknown Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy.
| S-EPMC5902970 | biostudies-literature